Infectious Disease Diagnostics Market Analysis North America,Europe,Asia,Rest of World (ROW) - US,Canada,Germany,UK,China - Size and Forecast 2022-2026

Published: Jun 2022

Pages: 123

SKU: IRTNTR73777

Snapshot

Infectious Disease Diagnostics Market Forecast 2022-2026

The infectious disease diagnostics market share is expected to increase to USD 13.94 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.7%.

The infectious disease diagnostics market report also offers information on several market vendors, including Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Trinity Biotech Plc, and Vela Diagnostics among others.

What will the Infectious Disease Diagnostics Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Market Size for the Forecast Period and Other Important Statistics

Market: Key Drivers, Trends, and Challenges

The increasing prevalence of infectious diseases is notably driving the market growth, although factors such as the availability of counterfeit drugs in developing economies may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic's impact on the industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Driver

One of the key factors driving the global market growth is the increasing prevalence of infectious diseases.
The outbreaks of infectious diseases have increased due to changing lifestyles, which result in reduced immunity.
The pattern of infection incidence has also been changing with the evolution of drug-resistant pathogens.
As per the Joint United Nations Programme on HIV/AIDS data of 2020, 680,000 people died from AIDS-related illnesses across the world.
The prevalence of meningococcal disease, which is caused by the bacterium Neisseria, meningitides, was decreased, owing to the meningococcal vaccines, which were licensed and made available in August 2020 in the US.
According to the CDC data for 2021, annually, almost 4,100 cases and 500 deaths occur due to meningococcal disease in the US.
The rise in the prevalence of infectious diseases is expected to drive the growth of the market in focus during the forecast period.

Significant Trend

Increase in M&A is one of the key infectious trends that is expected to impact the industry positively in the forecast period.
The vendors operating in the market are focusing on pursuing inorganic growth to tap into rapidly growing markets, such as India, Brazil, China, and South Africa.
In August 2021, Sanofi S.A acquired Translate Bio Inc., a clinical-stage mRNA therapeutics company, for over USD3 billion.
In April 2021, Pfizer Inc. acquired Amplyx Pharmaceuticals Inc., an American pharmaceutical company, with an aim to access the Fosmanogepix (APX001).
In May 2020, Novavax Inc., a biotechnology company specializing in next-generation vaccines, spent over USD160 million and acquired Praha Vaccines A.S.
A rise in M&A activities across the globe is anticipated to boost the growth of the market in the forecast years.

Key Challenge

One of the key challenges to global market growth is the availability of counterfeit drugs in developing economies.
The counterfeit products pose a challenge for global pharmaceutical manufacturers, costing them billions of dollars and negatively affecting their brand reputation.
Counterfeit drugs provide a false sense of security to the patients using them while endangering them even more with the contents of the products.
The counterfeits are widely available in low-income and developing countries because of insufficient regulations and manufacturing control.
The fear of stigma often makes HIV patients buy antiretrovirals through unauthorized retailers.
Due to the increase in the prevalence of AIDS in underdeveloped countries, such as India, Brazil, and Iran, counterfeiters may gain profits from the counterfeiting of antiretroviral drugs without easily being noticed.
The wide availability of counterfeit drugs may hamper the growth of the market in focus during the forecast period.

This market analysis and report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Who are the Major Infectious Disease Diagnostics Market Companies?

The report analyzes the market's competitive landscape and offers information on several market players, including:

This statistical study of the market encompasses successful business strategies deployed by the key vendors. The market is fragmented and the vendors are deploying growth strategies such as investment in research and development to compete in the market.

Product Insights and News

Abbott Laboratories - Under the established pharmaceuticals products segment, the company focuses on core laboratory, molecular solutions, point of care solutions, and rapid diagnostics.
Becton Dickinson and Co. - The BD Medical segment offers a range of medication delivery solutions, medication management solutions, diabetes care, and pharmaceutical systems.

The market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Market?

For more insights on the market share of various regions Request for a FREE sample now!

37% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.

The increase in the prevalence of infectious diseases, such as AIDS, TB, meningitis, influenza, and pneumonia will facilitate the market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating End-user Segments in the Infectious Disease Diagnostics Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The infectious disease diagnostics market share market growth and trends by the hospital segment will be significant during the forecast period. The growth is attributed to the increase in the number of patients suffering from different types of diseases, such as AIDS, tuberculosis (TB) meningitis, and COVID-19, globally. The growing presence of the large-, medium-, and small-sized hospitals that procure medical products, including infectious disease diagnostic instruments, in bulk from suppliers and group purchasing organizations (GPOs) will further boost the market growth.

Market Analyst Overview

The infectious disease diagnostics market thrives on breakthrough technologies like mass spectrometry and next-generation sequencing (NGS), enabling early diagnosis in healthcare settings. Point-of-care testing and molecular techniques offer cost-effective solutions, especially in emerging economies. Joint ventures and mergers facilitate the development of technologically advanced products and expand product lines. Regulatory guidelines and government-funded initiatives drive innovation and ensure the accuracy of diagnostic tools. With a focus on detecting bacterial infections and sexually transmitted diseases, the market addresses the rising incidence of infectious diseases, emphasizing the importance of accurate and timely screening in centralized laboratories.

Infectious Disease Diagnostics Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 6.7%
Market growth 2022-2026	USD 13.94 billion
Market structure	Fragmented
YoY growth (%)	5.11
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 37%
Key consumer countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Trinity Biotech Plc, and Vela Diagnostics
Market dynamics	Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in the Market Report?

CAGR of the market during the forecast period 2022-2026
Detailed information on factors that will drive the market growth and forecasting during the next five years
Precise estimation of the market size and its contribution to the parent market
Accurate predictions on upcoming market trends and analysis and changes in consumer behavior
The market research and growth of the industry across North America, Europe, Asia, and Rest of World (ROW)
A thorough analysis of the market's competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the market growth analysis of the market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 12: Market segments

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by End-user

5.1 Market segments
- Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
- Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)

5.2 Comparison by End-user
- Exhibit 26: Chart on Comparison by End-user
- Exhibit 27: Data Table on Comparison by End-user

5.3 Hospitals - Market size and forecast 2021-2026
- Exhibit 28: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)

5.4 Labs - Market size and forecast 2021-2026
- Exhibit 32: Chart on Labs - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Labs - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Labs - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Labs - Year-over-year growth 2021-2026 (%)

5.5 Market opportunity by End-user
- Exhibit 36: Market opportunity by End-user ($ million)

6 Customer Landscape

6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)

7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison

7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)

7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)

7.5 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)

7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

7.7 US - Market size and forecast 2021-2026
- Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)

7.8 Germany - Market size and forecast 2021-2026
- Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)

7.9 China - Market size and forecast 2021-2026
- Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)

7.10 UK - Market size and forecast 2021-2026
- Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)

7.11 Canada - Market size and forecast 2021-2026
- Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)

7.12 Market opportunity by geography
- Exhibit 78: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers

8.2 Market challenges

8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026

8.4 Market trends

9 Vendor Landscape

9.1 Overview

9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation

9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption

9.4 Industry risks
- Exhibit 82: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
- Exhibit 83: Vendors covered

10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification

10.3 Abbott Laboratories
- Exhibit 85: Abbott Laboratories - Overview
- Exhibit 86: Abbott Laboratories - Business segments
- Exhibit 87: Abbott Laboratories - Key news
- Exhibit 88: Abbott Laboratories - Key offerings
- Exhibit 89: Abbott Laboratories - Segment focus

10.4 Becton Dickinson and Co.
- Exhibit 90: Becton Dickinson and Co. - Overview
- Exhibit 91: Becton Dickinson and Co. - Business segments
- Exhibit 92: Becton Dickinson and Co. - Key news
- Exhibit 93: Becton Dickinson and Co. - Key offerings
- Exhibit 94: Becton Dickinson and Co. - Segment focus

10.5 Bio Rad Laboratories Inc.
- Exhibit 95: Bio Rad Laboratories Inc. - Overview
- Exhibit 96: Bio Rad Laboratories Inc. - Business segments
- Exhibit 97: Bio Rad Laboratories Inc. - Key news
- Exhibit 98: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 99: Bio Rad Laboratories Inc. - Segment focus

10.6 bioMerieux SA
- Exhibit 100: bioMerieux SA - Overview
- Exhibit 101: bioMerieux SA - Product / Service
- Exhibit 102: bioMerieux SA - Key offerings

10.7 DiaSorin SpA
- Exhibit 103: DiaSorin SpA - Overview
- Exhibit 104: DiaSorin SpA - Business segments
- Exhibit 105: DiaSorin SpA - Key offerings
- Exhibit 106: DiaSorin SpA - Segment focus

10.8 F. Hoffmann La Roche Ltd.
- Exhibit 107: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 108: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 109: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 110: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 111: F. Hoffmann La Roche Ltd. - Segment focus

10.9 Hologic Inc.
- Exhibit 112: Hologic Inc. - Overview
- Exhibit 113: Hologic Inc. - Business segments
- Exhibit 114: Hologic Inc. - Key news
- Exhibit 115: Hologic Inc. - Key offerings
- Exhibit 116: Hologic Inc. - Segment focus

10.10 QIAGEN NV
- Exhibit 117: QIAGEN NV - Overview
- Exhibit 118: QIAGEN NV - Product / Service
- Exhibit 119: QIAGEN NV - Key news
- Exhibit 120: QIAGEN NV - Key offerings

10.11 Thermo Fisher Scientific Inc.
- Exhibit 121: Thermo Fisher Scientific Inc. - Overview
- Exhibit 122: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 123: Thermo Fisher Scientific Inc. - Key news
- Exhibit 124: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 125: Thermo Fisher Scientific Inc. - Segment focus

10.12 Trinity Biotech Plc
- Exhibit 126: Trinity Biotech Plc - Overview
- Exhibit 127: Trinity Biotech Plc - Product / Service
- Exhibit 128: Trinity Biotech Plc - Key offerings

11 Appendix

11.1 Scope of the report

11.2 Inclusions and exclusions checklist
- Exhibit 129: Inclusions checklist
- Exhibit 130: Exclusions checklist

11.3 Currency conversion rates for US$
- Exhibit 131: Currency conversion rates for US$

11.4 Research methodology
- Exhibit 132: Research methodology
- Exhibit 133: Validation techniques employed for market sizing
- Exhibit 134: Information sources

11.5 List of abbreviations
- Exhibit 135: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

infectious disease diagnostics market market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis